Pharmaceuticals
Novo Nordisk’s Wegovy wins EU backing for reducing heart risks
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Novo Nordisk’s blockbuster Wegovy weight loss drug has received backing from the European Union’s medical regulator to expand the medicine’s use to include reducing the rise of serious heart events in overweight and obese adults. The Danish […]
Read More
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Weight loss drug concept. Cr | Istock | Getty Images Shares of Viking Therapeutics jumped 16% in premarket trading Thursday after the biotech company a day earlier announced plans to advance its experimental weight loss injection into a late-stage trial earlier than expected. It brings the San Diego-based company one step closer to joining the […]
Read More
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Sopa Images | Lightrocket | Getty Images Roche said Thursday that its Wegovy rival weight loss drugs will be part of a suite of medicines aimed at combatting the effects of obesity. CEO Thomas Schinecker welcomed positive early stage trial results from the firm’s two weight loss drug candidates as showing “best in disease potential.” […]
Read More
Pfizer’s gene therapy for rare genetic bleeding disorder succeeds in late-stage trial
Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the way for a potential approval. The treatment for hemophilia A could become the company’s second gene therapy to enter the U.S. market after Beqvez, which […]
Read More
Novo Nordisk’s Wegovy weight loss drug wins UK approval for use as a heart treatment
Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty Images LONDON — The U.K.’s health regulator on Tuesday approved the use of Novo Nordisk‘s Wegovy weight loss drug to reduce the risk of overweight and obese adults suffering from serious heart problems or strokes. The new approval from […]
Read More
Lawmakers introduce bipartisan bill aiming to crack down on drug middlemen as scrutiny ramps up
Feverpitched | Getty Images Bipartisan lawmakers introduced a new bill on Tuesday that aims to crack down on the business practices of drug supply chain middlemen who are widely accused of inflating prescription medication prices and harming U.S. patients and pharmacies. The legislation aims to ensure community pharmacies can provide care to patients enrolled in […]
Read More
CNBC Daily Open: Rising geopolitical risk
Traders work on the floor of the New York Stock Exchange during afternoon trading on April 09, 2024 in New York City. Michael M. Santiago | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no […]
Read More
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Novo Nordisk and Eli Lilly shares slid Wednesday after Roche announced promising early-stage trial data from its latest obesity drug candidate. The Swiss pharmaceutical giant said Wednesday that a second drug candidate from its purchase of Carmot Therapeutics indicated positive results, further heating up competition in the weight loss drug market. Roche shares jumped in […]
Read More
Just after leaving Google, Jakob Uszkoreit started out Inceptive to implement AI to drug progress
Prior to co-founding biotech startup Inceptive, Jakob Uszkoreit experienced an plan that would at some point make generative artificial intelligence doable. As a researcher at Google in 2017, Uszkoreit was striving to velocity up the training of neural networks. He advised utilizing a new way to interpret knowledge named self-notice. That thought gave way to […]
Read More
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward with a once-daily version of its weight loss pill, danuglipron, after it saw “encouraging” data in an ongoing early-stage trial. The company evaluated several once-daily formulations of the drug and identified one with “the most favorable profile.” Pfizer said it […]
Read More